Specialty Pharmacy

Treatment inhibits key process that enables cancer cells to multiply.

Notable outbreaks over the past 2 decades have qualified enterovirus D68 as an emerging pathogen.

Chronic inflammation may lead to development of aggressive form of cancer.

Specialty drug spending predicted to grow by more than 16% annually from 2015 to 2018.

Antiretroviral therapy provides similar benefits for stimulant users and non-users alike.

A hospital employee may have been in contact with clinical specimens from a deceased Ebola patient.

The second nurse to become infected with the Ebola virus after treating the index patient in Texas should not have been allowed to board a flight from Ohio earlier this week.

A second health care worker who tested positive for the Ebola virus traveled by air the day before her symptoms appeared.

The disease burden of smoking remains immense despite widespread tobacco cessation efforts.

SVR12 rates significantly higher in patients treated with daclatasvir/peginterferon alfa/ribavirin combination.

Bill Barre, RPh, vice president of business development at MedImpact Healthcare Systems, discusses MedImpact's Centers of Excellence program.

Pharmacy Times and Specialty Pharmacy Times add several new organizations to Strategic Alliance Partnership programs.

Nearly 700 children across 46 states are now infected with the severe respiratory illness.

Palbociclib provides first-line systemic treatment for women with advanced or metastatic breast cancer.

Investigators are working to resolve how a health care worker in Texas contracted the Ebola virus while caring for an infected patient.

Investigational bispecific T-cell engager antibody construct aids immune system in targeting cancer cells.

Diplomat Pharmacy, Inc, the nation's largest independent specialty pharmacy began trading its common stock the NYSE on October 10 in connection with its IPO.

Five US airports that receive the majority of travelers from West African nations will add new layers of entry screening.

In a retrospective study, investigators found that increases in total cholesterol and triglycerides were associated with an increased risk of biochemical recurrence in prostate cancer.

Provides use, cost forecast based on testing, future treatment rates.

The FDA today approved Gilead's Harvoni, the first combination pill to treat chronic hepatitis C virus genotype 1 infection.

The drug combination prevents nausea and vomiting after the start of cancer chemotherapy.

Brand name, patent-protected medications drive increasing costs.

Researcher urges caution in prescribing testosterone therapy in men who have not been diagnosed with hypogonadism.

Virus was undetectable for 3 years before researchers discovered viral reservoirs have not disappeared.

World Health Organization officials are stressing that clinical trials on Ebola vaccine candidates need to be expedited.

Howard Barsky, chief information officer for Armada Health Care, discusses how specialty pharmacies can improve services for patients through the use of data analytics.

Researchers in Finland are learning more about how hormones influence the risk of developing breast cancer, which may lead to a hormone-based treatment to reduce the risk of developing cancer later in life.

The child showed no symptoms of the respiratory virus prior to his death.

Findings of study provide new options for future vaccine development.